ID   MER34_HUMAN             Reviewed;         563 AA.
AC   Q9H9K5; B3KTB4; Q0P5R3; Q6NWN0;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   18-JUN-2025, entry version 142.
DE   RecName: Full=Endogenous retroviral envelope protein HEMO {ECO:0000305};
DE   AltName: Full=Endogenous retrovirus group MER34 member 1 Env polyprotein {ECO:0000305};
DE   AltName: Full=HERV-MER_4q12 provirus ancestral Env polyprotein;
DE   AltName: Full=Human endogenous MER34 (medium-reiteration-frequency-family-34) open reading frame {ECO:0000303|PubMed:28739914};
DE   AltName: Full=Human endogenous MER34 ORF {ECO:0000303|PubMed:28739914};
DE            Short=HEMO {ECO:0000303|PubMed:28739914};
DE   Contains:
DE     RecName: Full=Endogenous retroviral envelope protein HEMO, secreted form {ECO:0000305};
DE     AltName: Full=Endogenous retroviral envelope protein HEMO, 48 kDa form;
DE   Flags: Precursor;
GN   Name=ERVMER34-1 {ECO:0000312|HGNC:HGNC:42970};
GN   Synonyms=HEMO {ECO:0000303|PubMed:28739914}; ORFNames=LP9056;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H., Qiu X.,
RA   Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y., Shu H., Chen X.,
RA   Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S., Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, GLYCOSYLATION, PROTEOLYTIC PROCESSING, AND MUTAGENESIS OF
RP   352-CYS--GLY-355; 433-ARG--LEU-563; 472-PRO--LEU-563 AND 489-SER--LEU-563.
RX   PubMed=28739914; DOI=10.1073/pnas.1702204114;
RA   Heidmann O., Beguin A., Paternina J., Berthier R., Deloger M., Bawa O.,
RA   Heidmann T.;
RT   "HEMO, an ancestral endogenous retroviral envelope protein shed in the
RT   blood of pregnant women and expressed in pluripotent stem cells and
RT   tumors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 114:E6642-E6651(2017).
CC   -!- FUNCTION: Endogenous envelope proteins originate from retroviral
CC       envelope proteins, which mediate receptor recognition and membrane
CC       fusion during early infection. Endogenous envelope proteins may have
CC       kept, lost or modified their original function during evolution.
CC       {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Endogenous retroviral envelope protein HEMO]:
CC       Cell membrane {ECO:0000269|PubMed:28739914}; Single-pass type I
CC       membrane protein {ECO:0000255}. Note=This uncleaved form present at the
CC       cell surface represents the major form (PubMed:28739914).
CC       {ECO:0000269|PubMed:28739914}.
CC   -!- SUBCELLULAR LOCATION: [Endogenous retroviral envelope protein HEMO,
CC       secreted form]: Secreted {ECO:0000269|PubMed:28739914}. Note=This
CC       secreted form, which is released in the extracellular medium following
CC       cleavage, constitutes a minor form (PubMed:28739914).
CC       {ECO:0000269|PubMed:28739914}.
CC   -!- TISSUE SPECIFICITY: Expressed at high level in the placenta and stem
CC       cells (at protein level) (PubMed:28739914). Also expressed in the
CC       kidney but at a lower level (PubMed:28739914). Endogenous retroviral
CC       envelope protein HEMO, secreted form: Present in the blood of pregnant
CC       women (at protein level) (PubMed:28739914).
CC       {ECO:0000269|PubMed:28739914}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:28739914}.
CC   -!- PTM: [Endogenous retroviral envelope protein HEMO]: Cleaved by some
CC       metalloproteinase at 432-Gln-Arg-433 (mainly) or 433-Arg-Gln-434,
CC       leading to release the secreted form (Endogenous retroviral envelope
CC       protein HEMO, secreted form) in the extracellular medium.
CC       {ECO:0000269|PubMed:28739914}.
CC   -!- SIMILARITY: Belongs to the gamma type-C retroviral envelope protein
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH69998.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY189288; AAO86732.1; -; mRNA.
DR   EMBL; AK022746; BAB14220.1; -; mRNA.
DR   EMBL; AK095318; BAG53026.1; -; mRNA.
DR   EMBL; CH471057; EAX05439.1; -; Genomic_DNA.
DR   EMBL; BC067526; AAH67526.1; -; mRNA.
DR   EMBL; BC067528; AAH67528.1; -; mRNA.
DR   EMBL; BC067529; AAH67529.1; -; mRNA.
DR   EMBL; BC069998; AAH69998.1; ALT_FRAME; mRNA.
DR   RefSeq; NP_001229619.1; NM_001242690.2.
DR   RefSeq; NP_078810.1; NM_024534.6.
DR   AlphaFoldDB; Q9H9K5; -.
DR   BioGRID; 940070; 20.
DR   FunCoup; Q9H9K5; 1.
DR   IntAct; Q9H9K5; 10.
DR   STRING; 9606.ENSP00000460602; -.
DR   GlyCosmos; Q9H9K5; 2 sites, No reported glycans.
DR   GlyGen; Q9H9K5; 11 sites, 3 N-linked glycans (1 site), 1 O-linked glycan (2 sites).
DR   iPTMnet; Q9H9K5; -.
DR   PhosphoSitePlus; Q9H9K5; -.
DR   BioMuta; ERVMER34-1; -.
DR   DMDM; 74734033; -.
DR   jPOST; Q9H9K5; -.
DR   MassIVE; Q9H9K5; -.
DR   PaxDb; 9606-ENSP00000460602; -.
DR   PeptideAtlas; Q9H9K5; -.
DR   ProteomicsDB; 81327; -.
DR   TopDownProteomics; Q9H9K5; -.
DR   Antibodypedia; 63827; 5 antibodies from 5 providers.
DR   DNASU; 100288413; -.
DR   Ensembl; ENST00000440542.1; ENSP00000460255.1; ENSG00000226887.8.
DR   Ensembl; ENST00000443173.6; ENSP00000460602.1; ENSG00000226887.8.
DR   GeneID; 100288413; -.
DR   KEGG; hsa:100288413; -.
DR   MANE-Select; ENST00000443173.6; ENSP00000460602.1; NM_001242690.2; NP_001229619.1.
DR   UCSC; uc003gzr.4; human.
DR   AGR; HGNC:42970; -.
DR   CTD; 100288413; -.
DR   DisGeNET; 100288413; -.
DR   GeneCards; ERVMER34-1; -.
DR   HGNC; HGNC:42970; ERVMER34-1.
DR   HPA; ENSG00000226887; Tissue enhanced (parathyroid gland, placenta).
DR   OpenTargets; ENSG00000226887; -.
DR   VEuPathDB; HostDB:ENSG00000226887; -.
DR   eggNOG; ENOG502SD08; Eukaryota.
DR   GeneTree; ENSGT00870000136875; -.
DR   HOGENOM; CLU_483911_0_0_1; -.
DR   InParanoid; Q9H9K5; -.
DR   OMA; WRCADAN; -.
DR   OrthoDB; 9437663at2759; -.
DR   PAN-GO; Q9H9K5; 0 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9H9K5; -.
DR   PathwayCommons; Q9H9K5; -.
DR   BioGRID-ORCS; 100288413; 8 hits in 313 CRISPR screens.
DR   ChiTaRS; ERVMER34-1; human.
DR   GenomeRNAi; 100288413; -.
DR   Pharos; Q9H9K5; Tdark.
DR   PRO; PR:Q9H9K5; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q9H9K5; protein.
DR   Bgee; ENSG00000226887; Expressed in placenta and 95 other cell types or tissues.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   Gene3D; 1.10.287.210; -; 1.
DR   InterPro; IPR018154; TLV/ENV_coat_polyprotein.
DR   PANTHER; PTHR10424:SF78; ENDOGENOUS RETROVIRAL ENVELOPE PROTEIN HEMO; 1.
DR   PANTHER; PTHR10424; VIRAL ENVELOPE PROTEIN; 1.
DR   SUPFAM; SSF58069; Virus ectodomain; 1.
DR   neXtProt; NX_Q9H9K5; -.
DR   TreeFam; TF344098; -.
PE   1: Evidence at protein level;
KW   Cell membrane; ERV; Glycoprotein; Membrane; Proteomics identification;
KW   Reference proteome; Secreted; Signal; Transmembrane; Transmembrane helix;
KW   Transposable element.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000269|PubMed:28739914"
FT   CHAIN           27..563
FT                   /note="Endogenous retroviral envelope protein HEMO"
FT                   /id="PRO_0000341352"
FT   CHAIN           27..432
FT                   /note="Endogenous retroviral envelope protein HEMO,
FT                   secreted form"
FT                   /evidence="ECO:0000305|PubMed:28739914"
FT                   /id="PRO_0000443800"
FT   TOPO_DOM        27..488
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        489..509
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        510..563
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        122
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        192
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   MUTAGEN         352..355
FT                   /note="CTQG->RTKR: Introduction of a furin cleavage site,
FT                   promoting proteolytic cleavage of the protein by furin and
FT                   release in the extracellular medium."
FT                   /evidence="ECO:0000269|PubMed:28739914"
FT   MUTAGEN         433..563
FT                   /note="Missing: Promotes release in the extracellular
FT                   medium."
FT                   /evidence="ECO:0000269|PubMed:28739914"
FT   MUTAGEN         472..563
FT                   /note="Missing: Promotes release in the extracellular
FT                   medium."
FT                   /evidence="ECO:0000269|PubMed:28739914"
FT   MUTAGEN         489..563
FT                   /note="Missing: Promotes release in the extracellular
FT                   medium."
FT                   /evidence="ECO:0000269|PubMed:28739914"
FT   CONFLICT        34
FT                   /note="T -> A (in Ref. 4; AAH69998)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        81
FT                   /note="W -> R (in Ref. 4; AAH67529)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        418
FT                   /note="S -> P (in Ref. 4; AAH67529)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        434
FT                   /note="Q -> R (in Ref. 4; AAH67529)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        459
FT                   /note="Q -> H (in Ref. 4; AAH69998)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   563 AA;  63547 MW;  D8D0B75216FDF8B7 CRC64;
     MGSLSNYALL QLTLTAFLTI LVQPQHLLAP VFRTLSILTN QSNCWLCEHL DNAEQPELVF
     VPASASTWWT YSGQWMYERV WYPQAEVQNH STSSYRKVTW HWEASMEAQG LSFAQVRLLE
     GNFSLCVENK NGSGPFLGNI PKQYCNQILW FDSTDGTFMP SIDVTNESRN DDDDTSVCLG
     TRQCSWFAGC TNRTWNSSAV PLIGLPNTQD YKWVDRNSGL TWSGNDTCLY SCQNQTKGLL
     YQLFRNLFCS YGLTEAHGKW RCADASITND KGHDGHRTPT WWLTGSNLTL SVNNSGLFFL
     CGNGVYKGFP PKWSGRCGLG YLVPSLTRYL TLNASQITNL RSFIHKVTPH RCTQGDTDNP
     PLYCNPKDNS TIRALFPSLG TYDLEKAILN ISKAMEQEFS ATKQTLEAHQ SKVSSLASAS
     RKDHVLDIPT TQRQTACGTV GKQCCLYINY SEEIKSNIQR LHEASENLKN VPLLDWQGIF
     AKVGDWFRSW GYVLLIVLFC LFIFVLIYVR VFRKSRRSLN SQPLNLALSP QQSAQLLVSE
     TSCQVSNRAM KGLTTHQYDT SLL
//
